Arcapta Neohaler (Novartis Pharmaceuticals Corporation)


Welcome to the PulseAid listing for the Arcapta Neohaler drug offered from Novartis Pharmaceuticals Corporation. This Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Novartis Pharmaceuticals Corporation
NON-PROPRIETARY NAME: Indacaterol maleate
SUBSTANCE NAME: INDACATEROL MALEATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
ROUTE: ORAL; RESPIRATORY (INHALATION)
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-07-01
END MARKETING DATE: 0000-00-00


Arcapta Neohaler HUMAN PRESCRIPTION DRUG Details:

Item DescriptionArcapta Neohaler from Novartis Pharmaceuticals Corporation
LABELER NAME: Novartis Pharmaceuticals Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 75(ug/1)
START MARKETING DATE: 2011-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0078-0619_dd22d6db-adf4-4e36-b243-c23f3d4ba08e
PRODUCT NDC: 0078-0619
APPLICATION NUMBER: NDA022383

Other INDACATEROL MALEATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Novartis Pharmaceuticals CorporationArcapta Neohaler
Sunovion Pharmaceuticals Inc.ARCAPTA NEOHALER